Lipid inflammatory mediators in diabetic vascular disease
- PMID: 15166011
- DOI: 10.1161/01.ATV.0000133606.69732.4c
Lipid inflammatory mediators in diabetic vascular disease
Abstract
Type 2 diabetes is associated with significantly accelerated rates of macrovascular complications such as atherosclerosis. Emerging evidence now indicates that atherosclerosis is an inflammatory disease and that certain inflammatory markers may be key predictors of diabetic atherosclerosis. Proinflammatory cytokines and cellular adhesion molecules expressed by vascular and blood cells during stimulation by growth factors and cytokines seem to play major roles in the pathophysiology of atherosclerosis and diabetic vascular complications. However, more recently, data suggest that inflammatory responses can also be elicited by smaller oxidized lipids that are components of atherogenic oxidized low-density lipoprotein or products of phospholipase activation and arachidonic acid metabolism. These include oxidized lipids of the lipoxygenase and cyclooxygenase pathways of arachidonic acid and linoleic acid metabolism. These lipids have potent growth, vasoactive, chemotactic, oxidative, and proinflammatory properties in vascular smooth muscle cells, endothelial cells, and monocytes. Cellular and animal models indicate that these enzymes are induced under diabetic conditions, have proatherogenic effects, and also mediate the actions of growth factors and cytokines. This review highlights the roles of the inflammatory cyclooxygenase and 12/15-lipoxygenase pathways in the pathogenesis of diabetic vascular disease. Evidence suggests that inflammatory responses in the vasculature can be elicited by small oxidized lipids that are components of oxidized low-density lipoprotein or products of the lipoxygenase and cyclooxygenase pathways of arachidonic and linoleic acid metabolism. This review evaluates these inflammatory and proatherogenic pathways in the pathogenesis of diabetic vascular disease.
Similar articles
-
Linoleic acid, but not oleic acid, upregulates production of interleukin-8 by human vascular smooth muscle cells via arachidonic acid metabolites under conditions of oxidative stress.J Soc Gynecol Investig. 2005 Dec;12(8):593-8. doi: 10.1016/j.jsgi.2005.09.004. J Soc Gynecol Investig. 2005. PMID: 16325749
-
Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance.Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):487-96. doi: 10.1161/01.ATV.0000155325.41507.e0. Epub 2005 Jan 6. Arterioscler Thromb Vasc Biol. 2005. PMID: 15637306 Review.
-
Roles of lipid mediators in kidney injury.Semin Nephrol. 2007 May;27(3):338-51. doi: 10.1016/j.semnephrol.2007.02.008. Semin Nephrol. 2007. PMID: 17533010 Review.
-
The two faces of the 15-lipoxygenase in atherosclerosis.Prostaglandins Leukot Essent Fatty Acids. 2007 Aug;77(2):67-77. doi: 10.1016/j.plefa.2007.08.001. Epub 2007 Sep 14. Prostaglandins Leukot Essent Fatty Acids. 2007. PMID: 17869078 Review.
-
[Abnormal arachidonate metabolites in diabetes mellitus].Nihon Rinsho. 1990 Dec;48 Suppl:767-72. Nihon Rinsho. 1990. PMID: 2128347 Japanese. No abstract available.
Cited by
-
Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract.BMC Complement Altern Med. 2016 Aug 12;16(1):286. doi: 10.1186/s12906-016-1251-5. BMC Complement Altern Med. 2016. PMID: 27520089 Free PMC article.
-
Monocyte 15-lipoxygenase gene expression requires ERK1/2 MAPK activity.J Immunol. 2010 Nov 1;185(9):5211-24. doi: 10.4049/jimmunol.1000514. Epub 2010 Sep 22. J Immunol. 2010. PMID: 20861348 Free PMC article.
-
Recent development of lipoxygenase inhibitors as anti-inflammatory agents.Medchemcomm. 2017 Nov 29;9(2):212-225. doi: 10.1039/c7md00390k. eCollection 2018 Feb 1. Medchemcomm. 2017. PMID: 30108915 Free PMC article. Review.
-
Immunopathology of mastitis: insights into disease recognition and resolution.J Mammary Gland Biol Neoplasia. 2011 Dec;16(4):291-304. doi: 10.1007/s10911-011-9230-4. Epub 2011 Sep 22. J Mammary Gland Biol Neoplasia. 2011. PMID: 21938490 Review.
-
Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice.Circ Res. 2008 Sep 12;103(6):615-23. doi: 10.1161/CIRCRESAHA.108.175190. Epub 2008 Aug 7. Circ Res. 2008. Retraction in: Circ Res. 2009 Sep 11;105(6):e9. doi: 10.1161/RES.0b013e3181bc3a4d PMID: 18688044 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials